
Clorox remains a defensive dividend play, appealing to long-term income-focused investors despite recent stock weakness. I see the premium valuation as a limiting factor, suggesting potential for price consolidation rather than outperformance. Turnaround potential exists if volatility returns, economic headwinds favor staples, or growth accelerates as analysts anticipate.










